Molecular recognition in the sphingosine 1-phosphate receptor family.

Computational modeling and its application in ligand screening and ligand receptor interaction studies play important roles in structure-based drug design. A series of sphingosine 1-phosphate (S1P) receptor ligands with varying potencies and receptor selectivities were docked into homology models of the S1P(1-5) receptors. These studies provided molecular insights into pharmacological trends both across the receptor family as well as at single receptors. This study identifies ligand recognition features that generalize across the S1P receptor family, features unique to the S1P(4) and S1P(5) receptors, and suggests significant structural differences of the S1P(2) receptor. Docking results reveal a previously unknown sulfur-aromatic interaction between the S1P(4) C5.44 sulfur atom and the phenyl ring of benzimidazole as well as pi-pi interaction between F3.33 of S1P(1,4,5) and aromatic ligands. The findings not only confirm the importance of a cation-pi interaction between W4.64 and the ammonium of S1P at S1P(4) but also predict the same interaction at S1P(5). S1P receptor models are validated for pharmacophore development including database mining and new ligand discovery and serve as tools for ligand optimization to improve potency and selectivity.

[1]  G. Miotto,et al.  Ganglioside GM1 protection from apoptosis of rat heart fibroblasts. , 1999, Archives of biochemistry and biophysics.

[2]  Peter L. Freddolino,et al.  Prediction of structure and function of G protein-coupled receptors , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[3]  T. Kanda,et al.  Extracellular mechanism through the Edg family of receptors might be responsible for sphingosine-1-phosphate-induced regulation of DNA synthesis and migration of rat aortic smooth-muscle cells , 2000 .

[4]  John Calvin Reed,et al.  Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine -1-phosphate therapy , 2000, Nature Medicine.

[5]  T. Hla,et al.  An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors. , 1990, The Journal of biological chemistry.

[6]  D. Brindley,et al.  Platelet-released phospholipids link haemostasis and angiogenesis. , 2001, Cardiovascular research.

[7]  A. Parrill,et al.  S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate. , 2005, Chemistry & biology.

[8]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998 .

[9]  T. Billiar,et al.  Sphingosine 1-Phosphate Protects Human Umbilical Vein Endothelial Cells from Serum-deprived Apoptosis by Nitric Oxide Production* , 2001, The Journal of Biological Chemistry.

[10]  H. Rosen,et al.  Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists , 2002, Science.

[11]  Marcus Elstner,et al.  The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure. , 2004, Journal of molecular biology.

[12]  Y. Yatomi,et al.  Induction and suppression of endothelial cell apoptosis by sphingolipids: a possible in vitro model for cell-cell interactions between platelets and endothelial cells. , 1999, Blood.

[13]  A. Parrill,et al.  A Single Amino Acid Determines Lysophospholipid Specificity of the S1P1 (EDG1) and LPA1 (EDG2) Phospholipid Growth Factor Receptors* , 2001, The Journal of Biological Chemistry.

[14]  Y. Fujiwara,et al.  Sphingosine 1-phosphate analogue recognition and selectivity at S1P4 within the endothelial differentiation gene family of receptors. , 2005, The Biochemical journal.

[15]  G. Shaw,et al.  Cloning and Characterization of a Putative G-Protein Coupled Receptor Potentially Involved in Development , 1994, Molecular and Cellular Neuroscience.

[16]  Michael D. Davis,et al.  Synthesis of benzimidazole based analogues of sphingosine-1-phosphate: discovery of potent, subtype-selective S1P4 receptor agonists. , 2004, Bioorganic & medicinal chemistry letters.

[17]  Haruki Nakamura,et al.  Announcing the worldwide Protein Data Bank , 2003, Nature Structural Biology.

[18]  B. O'dowd,et al.  Characterization of a Novel Sphingosine 1-Phosphate Receptor, Edg-8* , 2000, The Journal of Biological Chemistry.

[19]  Katrin Sangkuhl,et al.  Mutant G-protein-coupled receptors as a cause of human diseases. , 2004, Pharmacology & therapeutics.

[20]  J. P. Hobson,et al.  EDG‐1 links the PDGF receptor to Src and focal adhesion kinase activation leading to lamellipodia formation and cell migration , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  L. Weinstein,et al.  Inherited diseases involving g proteins and g protein-coupled receptors. , 2004, Annual review of medicine.

[22]  A. Parrill,et al.  Sphingosine 1-phosphate pKa and binding constants: intramolecular and intermolecular influences. , 2007, Journal of molecular graphics & modelling.

[23]  Y. Fujiwara,et al.  Identification of the Hydrophobic Ligand Binding Pocket of the S1P1 Receptor* , 2007, Journal of Biological Chemistry.

[24]  Y. Yatomi,et al.  EDG1 Is a Functional Sphingosine-1-phosphate Receptor That Is Linked via a Gi/o to Multiple Signaling Pathways, Including Phospholipase C Activation, Ca2+Mobilization, Ras-Mitogen-activated Protein Kinase Activation, and Adenylate Cyclase Inhibition* , 1998, The Journal of Biological Chemistry.

[25]  D. Stainier,et al.  A sphingosine-1-phosphate receptor regulates cell migration during vertebrate heart development , 2000, Nature.

[26]  T. Halgren.  Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94 , 1996, J. Comput. Chem..

[27]  S. Coughlin,et al.  Identification of cDNAs encoding two G protein‐coupled receptors for lysosphingolipids 1 , 1997, FEBS letters.

[28]  P. Lindley,et al.  Sulphur‐aromatic interactions in proteins , 1985 .

[29]  T. Pham,et al.  Peptide design and structural characterization of a GPCR loop mimetic. , 2007, Biopolymers.

[30]  James I. Fells,et al.  A single amino acid determines preference between phospholipids and reveals length restriction for activation ofthe S1P4 receptor , 2004, BMC Biochemistry.

[31]  Yael Marantz,et al.  Modeling the 3D structure of GPCRs: advances and application to drug discovery. , 2003, Current opinion in drug discovery & development.

[32]  T. Yoneya,et al.  Edg-6 as a putative sphingosine 1-phosphate receptor coupling to Ca(2+) signaling pathway. , 2000, Biochemical and biophysical research communications.

[33]  M. Ferrer,et al.  A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonists. , 2004, Journal of medicinal chemistry.

[34]  C. H. Liu,et al.  Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. , 1998, Science.

[35]  N. Gray,et al.  Sphingosine 1-Phosphate (S1P) Receptor Subtypes S1P1 and S1P3, Respectively, Regulate Lymphocyte Recirculation and Heart Rate* , 2004, Journal of Biological Chemistry.

[36]  Yang Zhang,et al.  Structure Modeling of All Identified G Protein–Coupled Receptors in the Human Genome , 2006, PLoS Comput. Biol..

[37]  V. Brinkmann,et al.  FTY720: altered lymphocyte traffic results in allograft protection. , 2001, Transplantation.

[38]  J. P. Hobson,et al.  Sphingosine 1-Phosphate Stimulates Cell Migration through a Gi-coupled Cell Surface Receptor , 1999, The Journal of Biological Chemistry.

[39]  K. Palczewski,et al.  Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.

[40]  Mee‐Hyun Lee,et al.  Syntheses of sphingosine-1-phosphate analogues and their interaction with EDG/S1P receptors. , 2004, Bioorganic & medicinal chemistry letters.

[41]  J. P. Hobson,et al.  Sphingosine-1-phosphate is a ligand for the G protein-coupled receptor EDG-6. , 2000, Blood.

[42]  W. Erl,et al.  Sphingosine-1-phosphate and the leading Edg-1 of vascular smooth muscle cells. , 2001, Circulation research.